Wordt geladen...
Bayesian designs to account for patient heterogeneity in phase II clinical trials
PURPOSE OF REVIEW: Between-patient heterogeneity is very common in clinical trials. This complicates treatment evaluation, due to known prognostic subgroup effects or potential treatment-subgroup interactions. We review two Bayesian phase II clinical trial designs that account explicitly for patient...
Bewaard in:
| Gepubliceerd in: | Curr Opin Oncol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5555403/ https://ncbi.nlm.nih.gov/pubmed/18525336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e328302163c |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|